Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2000
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2379327A1 Pneumococcal surface protein combination vaccine
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376479A1 Retro-inverso peptides derived from interleukin-6
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2376288A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods
12/21/2000CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000CA2375155A1 Protein localization assays for toxicity and antidotes thereto
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/20/2000EP1061129A1 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
12/20/2000EP1061077A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060193A2 Cd147 binding molecules as therapeutics
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060175A2 Tryptase inhibitors
12/20/2000EP1060173A2 Benzazine derivatives phosphodiesterase 4 inhibitors
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP1060163A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
12/20/2000EP1059937A2 Il-12 enhancement of immune responses to t-independent antigens
12/20/2000EP1059936A1 Il-12 stimulation of neonatal immunity
12/20/2000EP1059932A1 Method for reducing susceptibility to hiv infection
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059913A1 Emulsion preconcentrates containing cyclosporin or a macrolide
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0877555A4 Method of inhibiting immune system destruction of transplanted viable cells
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277020A Application of Eight precious extract in preparing antiviral medicine
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
12/19/2000US6162790 Oligopeptides
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/19/2000CA2000420C Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075304A1 Immunostimulant oligonucleotide
12/14/2000WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075144A2 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075130A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
12/14/2000WO2000075126A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000WO2000075117A1 Compositions and methods for inhibiting cell death
12/14/2000WO2000075114A1 Beta2-adrenoceptor agonists
12/14/2000WO2000075113A1 Novel heterocyclic carboxamide derivatives
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074716A2 Ige peptides for allergy immunotherapy
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074714A2 Indicators for monitoring the technique of transcutaneous immunization
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074708A1 Method for treating endotoxic shock and inflammatory and autoimmune diseases in mammals
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074696A1 Combination of glucosamine with herbal extracts of tripterygium, ligustrum and erycibe
12/14/2000WO2000074693A2 Immunity generation
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049409A3 ASSAY FOR THE IDENTIFICATION OF IgE ANTIBODY SUPPRESSORS
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000045770A3 Compressed lecithin preparations
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000044408A3 Method of treating demyelinating inflammatory disease using ccr1 antagonists
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000015264A9 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000DE19926475A1 Träger-Pharmaka-Konjugate Carrier conjugates drugs
12/14/2000CA2390948A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000CA2390090A1 Peptides
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376634A1 Immunostimulant oligonucleotide
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2376010A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000CA2376008A1 Combination of glucosamine with herbal extracts of tripterygium, ligustrum and erycibe
12/14/2000CA2375985A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
1 ... 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 ... 1172